Gerard Gallagher is an Editorial Director at Healio. With over 20 years of experience, he specializes in medicine and healthcare, covering topics such as public health, pharmaceutical regulation, and healthcare administration. Gallagher's work has been featured in Healio, where he continues to contribute to the discourse on health and wellness.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Gerard Gallagher’s coverage primarily focuses on healthcare and pharmaceuticals, with a strong emphasis on infectious diseases, public health, medical research, and vaccines. His articles often cite data and provide expert commentary. To effectively reach out to Gerard Gallagher, consider providing insights or data-backed analysis related to developments in the field of infectious diseases or public health. Experts who can offer valuable perspectives on vaccine development or healthcare preparedness for pandemics would likely be of interest to him.
When reaching out to Gerard Gallagher with pitches for potential stories or expert commentary, it's important to ensure that the content aligns closely with his areas of focus within the healthcare sector. Additionally, given his lack of specified geographic focus but broad international themes covered in healthcare and pharmaceutical fields, he may appreciate insights from global experts as well as those focusing specifically on the US context when relevant.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Gerard Gallagher, Sara Kellner
Testing all infants in the neonatal ICU for congenital cytomegalovirus could catch twice as many cases as targeted screening of infants who fail their newborn hearing test, according to the results of a study at Cleveland Clinic.
By: Gerard Gallagher, Anthony Stitt
Three Florida counties have declared states of emergency due to a surge in locally acquired dengue fever, a mosquito-borne illness that has circulated in Florida for years.
By: Naomi Lawrence-Reid, Sara Kellner, Gerard Gallagher
Growing up, Naomi Lawrence-Reid, MD, always knew she wanted to be a doctor.
By: Anthony Stitt, Gerard Gallagher
Merck has decided to discontinue production of a combination antibiotic used in hospitals to target life-threatening infections resistant to other medications.
By: Gerard Gallagher, Sara Kellner
SAN DIEGO — TikTok videos with misinformation about acetaminophen and autism received more views than posts with evidence-based information last fall after federal officials claimed a link between the two, researchers found.
By: Gerard Gallagher, Anthony Stitt, Caitlyn Stulpin
The CDC, WHO and other agencies said they are monitoring the situation surrounding the death of a laboratory worker in Russia who worked at an institute focused on plague research.
Chima J. Ohuabunwo MD, MPH a CDC-trained epidemiologist with on-the-ground experience in the largest Ebola virus outbreak in history, praised Kenya's response this week to its first Ebola case.
WASHINGTON — A large real-world study of people who switched from daily oral therapy to long-acting injections for HIV treatment showed that most stuck with the long-acting regimen and few experienced virologic failure.The results could help alleviate providers’ concerns about the perceived challenges of remaining on a long-acting regimen for HIV, according to Ricky Hsu, MD, medical
By: Gerard Gallagher, Sara Kellner
WASHINGTON — Neutralizing antibodies against measles fell below detectable levels by age 6 months for most infants included in a study presented at IDWeek.
By: Caitlyn Stulpin, Gerard Gallagher
Federal data published Tuesday showed an increase in infections and deaths related to drug resistance in the United States since the last time the CDC issued a report on the subject years ago.
